Table 1 Characteristics of each eye in this study.

From: Full-thickness macular hole formation in proliferative diabetic retinopathy

Age

Gender

Laterality

SEa

Initial BCVA, logMAR (Snellen Equivalent)

Lens status

FVP severity

FVP locations

MH minimal diameter (μm)

MH basal diameter (μm)

MHRD

Type of MH formation

Late foveal contour

Final BCVA, logMAR (Snellen Equivalent)

55

F

R

2.25

1.301 (20/400)

Phakic

1

Central

456

1039

N

2

U

0.398 (20/50)

41

M

L

9.00

2 (20/2000)

Phakic

3

Widespread

239

N/A

Y

4

U

0.824 (20/133)

66

F

L

0.523 (20/67)

Pseudophakic

1

Central

259

594

N

2

U

0.824 (20/133)

63

F

R

3.00

1.9 (20/1589)

Phakic

4

Widespread

884

N/A

Y

2

W

2 (20/2000)

38

F

L

− 3.75

1.495 (20/625)

Phakic

2

Incomplete

640

N/A

Y

1

V

0.796 (20/125)

57

F

R

0.50

1.301 (20/400)

Phakic

2

Incomplete

632

N/A

Y

3

partially attached

2.4 (20/5024)

53

F

R

− 0.25

0.699 (20/100)

Phakic

2

Incomplete

213

213

N

1

U

0.523 (20/67)

39

F

R

− 1.00

2 (20/2000)

Phakic

2

Complete

710

N/A

Y

4

  

54

M

L

2.00

1.301 (20/400)

Phakic

2

Incomplete

472

838

N

1

U

0.699 (20/100)

47

F

R

1.50

1.398 (20/500)

Phakic

3

Complete

610

N/A

Y

3

U

0.699 (20/100)

69

F

R

1.75

2.3 (20/3990)

Phakic

1

Central

136

N/A

Y

1

W

2.4 (20/5024)

53

F

L

− 0.25

1.398 (20/500)

Phakic

2

Incomplete

322

1778

Y

1

V

0.301 (20/40)

45

F

L

− 1.25

0.699 (20/100)

Phakic

2

Incomplete

173

482

N

2

U

0.398 (20/50)

59

M

R

0.75

1.699 (20/1000)

Phakic

2

Incomplete

164

N/A

Y

2

U

0.824(20/133)

29

F

R

− 2.00

0.824 (20/133)

Phakic

3

Incomplete

452

N/A

Y

3

V

0.201 (20/32)

43

F

L

− 1.00

1.301 (20/400)

Phakic

2

Incomplete

579

N/A

Y

4

W

0.398 (20/50)

40

M

L

− 1.50

0.699 (20/100)

Phakic

2

Incomplete

401

1296

N

2

U

2 (20/2000)

59

F

R

1.50

1.9 (20/1589)

Phakic

4

Widespread

598

N/A

Y

2

U

2 (20/2000)

59

F

L

2.25

1.9 (20/1589)

Pseudophakic

3

Incomplete

517

N/A

Y

3

W

2 (20/2000)

60

M

L

− 0.50

1 (20/200)

Phakic

1

Incomplete

252

1459

N

2

W

1 (20/200)

45

M

L

− 0.25

1.699 (20/1000)

Phakic

3

Incomplete

352

N/A

Y

1

W

2 (20/2000)

  1. BCVA best-corrected visual acuity, Complete complete arcade type, F female, FVP fibrovascular proliferation, Incomplete incomplete arcade type, M male, MH macular hole, MHRD macular hole retinal detachment, N no (no MHRD), N/A not applicable, SE spherical equivalent, Y yes (MHRD).
  2. a1/21 SE was not available.